| dc.contributor.advisor | Mendoza Gómez, Luis | |
| dc.contributor.author | Calvo Trujillo, Maiween Aura Luz | |
| dc.date.accessioned | 2022-04-27T16:53:23Z | |
| dc.date.available | 2022-04-27T16:53:23Z | |
| dc.date.issued | 2018 | |
| dc.description.abstract | La enfermedad de Parkinson es el segundo trastorno neurodegenerativo más común después de la enfermedad de Alzheimer, afectando la calidad de vida, no sólo de la persona que lo padece, sino también a su entorno familiar. Se ha sugerido la interacción entre la susceptibilidad genética y la exposición a factores ambientales; considerando los pesticidas como un factor de riesgo potencialmente alto debido a su toxicidad y efectos neurodegenerativos. San Juan Nepomuceno es un municipio cuya principal actividad económica es la agricultura y la ganadería, lo cual permite el uso frecuente de pesticidas y la exposición a estos por parte de los campesinos y otros habitantes del municipio. Este estudio de investigación tiene como objetivo principal determinar la relación entre la exposición a pesticidas y la prevalencia de enfermedad de Parkinson en el municipio de San Juan Nepomuceno, Bolívar. Teniendo en cuenta un enfoque cuantitativo, con diseño epidemiológico observacional analítico de casos y controles. De esta manera, se buscan reforzar las medidas preventivas sobre el uso de pesticidas y disminuir la incidencia y prevalencia de enfermedad de Parkinson. | spa |
| dc.description.degreelevel | Maestría | spa |
| dc.description.degreename | Magíster en Toxicología | spa |
| dc.format.extent | 33 hojas | spa |
| dc.format.mimetype | application/pdf | spa |
| dc.identifier.uri | https://hdl.handle.net/11227/15073 | |
| dc.identifier.uri | http://dx.doi.org/10.57799/11227/2103 | |
| dc.language.iso | spa | spa |
| dc.publisher | Universidad de Cartagena | spa |
| dc.publisher.faculty | Facultad de Medicina | spa |
| dc.publisher.place | Cartagena de Indias | spa |
| dc.publisher.program | Maestría en Toxicología | spa |
| dc.rights | Derechos Reservados - Universidad de Cartagena, 2018 | spa |
| dc.rights.accessrights | info:eu-repo/semantics/openAccess | spa |
| dc.rights.creativecommons | Atribución-NoComercial 4.0 Internacional (CC BY-NC 4.0) | spa |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc/4.0/ | spa |
| dc.subject.armarc | Cerebro - Enfermedades | |
| dc.subject.armarc | Enfermedad de párkinson | |
| dc.subject.armarc | Enfermedad de párkinson - Pacientes; | |
| dc.subject.armarc | Daño cerebral | |
| dc.title | Exposición a pesticidas como factor de riesgo para enfermedad de parkinson: un estudio caso-control en el municipio de San Juan Nepomuceno | spa |
| dc.type | Trabajo de grado - Maestría | spa |
| dc.type.coar | http://purl.org/coar/resource_type/c_bdcc | spa |
| dc.type.content | Text | spa |
| dc.type.driver | info:eu-repo/semantics/masterThesis | spa |
| dc.type.redcol | https://purl.org/redcol/resource_type/TM | spa |
| dc.type.version | info:eu-repo/semantics/publishedVersion | spa |
| dcterms.references | Ariza-Serrano LM, Guerrero-Vega J, Ortiz P, Moreno-Lopez CL. Caracterización de pacientes con enfermedad de Parkinson en un centro de referencia de la ciudad de Bogotá, Colombia. Acta Neurológica Colombiana. 2016;32(3):203-8. | spa |
| dcterms.references | Pinhel MAdS, Sado CL, Longo GdS, Gregorio ML, Amorim GS, Florim GMdS, et al. Nullity of GSTT1/GSTM1 related to pesticides is associated with Parkinson's disease. Arquivos de neuro-psiquiatria. 2013;71(8):527-32. | spa |
| dcterms.references | Iknurov Mollov A, Martinez Ponce DC, Serrano Puebla JM, Elias Salcedo S. Exposición a pesticidas en el ámbito laboral, expresión genética y enfermedad de Parkinson. Medicina y Seguridad del Trabajo. 2017;63(246):68-84 | spa |
| dcterms.references | Diazgranados Sánchez JA, Chan Guevara L, Gómez Betancourt LF, Lozano Arango AF, Ramirez M. Description of Parkinson disease population in a neurological medical center in Cali, Colombia. Acta Neurológica Colombiana. 2011;27(4):205-10. | spa |
| dcterms.references | Toro AC, Buriticá OF. Enfermedad de parkinson: criterios diagnósticos, factores de riesgo y de progresión, y escalas de valoración del estadio clínico. Acta Neurol Colomb. 2014;30(4):300-6. | spa |
| dcterms.references | Sequeira Quesada CM, Arias Rivera D. Presencia de pesticidas en la dieta como factor de riesgo para el parkinson esporádico. Revista Médica de la Universidad de Costa Rica Vol 7 Núm 2. 2014 | spa |
| dcterms.references | Dawson TM, Dawson VL. Rare genetic mutations shed light on the pathogenesis of Parkinson disease. The Journal of clinical investigation. 2003;111(2):145-51. | spa |
| dcterms.references | Horowitz M, Greenamyre J. Gene–environment interactions in Parkinson's disease: the importance of animal modeling. Clinical Pharmacology & Therapeutics. 2010;88(4):467-74. | spa |
| dcterms.references | Gómez-Chavarín M, Torres-Ortiz M, Perez-Soto G. Interacción entre factores genéticos-ambientales y la epigénesis de la enfermedad de Parkinson. Archivos de Neurociencias. 2016;21(1):32-44. | spa |
| dcterms.references | Figueroa PR. La enfermedad del Parkinson y las sustancias químicas. Investiga TEC. 2016(26):2. | spa |
| dcterms.references | van der Mark M, Vermeulen R, Nijssen PC, Mulleners WM, Sas AM, van Laar T, et al. Occupational exposure to solvents, metals and welding fumes and risk of Parkinson's disease. Parkinsonism & related disorders. 2015;21(6):635-9. | spa |
| dcterms.references | Yucra S, Gasco M, Rubio J, Gonzales GF. Exposición ocupacional a plomo y pesticidas órganofosforados: efecto sobre la salud reproductiva masculina. Revista peruana de medicina experimental y salud pública. 2008;25(4):394-402. | spa |
| dcterms.references | Ortiz GG, Moisés FPP, Macías-Islas MÁ, Jiménez-Gil FJ, Miranda-Díaz AG, Flores-Alvarado LJ, et al. Toxicidad de plaguicidas y su asociación con la enfermedad de Parkinson. Arch Neurocien (Mex). 2011;16(1):33-9. | spa |
| dcterms.references | Bolívar SOdSSJN. Análisis de Situación de Salud con el Modelo de los Determinantes Sociales de Salud del Municipio San Juan Nepomuceno Bolívar. 2015:1- 134. | spa |
| dcterms.references | Correal Ximena, July. F. Información estadística contexto regional departamento de Bolívar Cartagena de Indias, Distrito Turístico y Cultural, Municipios de San Jacinto, San Juan Nepomuceno y Turbaco Mayo de 2015;Boletin N.8:1- 43. | spa |
| dcterms.references | Guardela Osorio LM. Memorias de rectificación y canalización de los arroyos Salvador-Catalina. 2016. | spa |
| dcterms.references | RIVERA DM. DINÁMICA PRODUCTIVA AGRÍCOLA EN LOS MONTES DE MARÍA. 2010. | spa |
| dcterms.references | Martínez-Fernández R, Gasca-Salas C, Sánchez-Ferro Á, Obeso JÁ. Actualización en la enfermedad de parkinson. Revista Médica Clínica Las Condes. 2016;27(3):363-79. | spa |
| dcterms.references | Freire C, Koifman S. Pesticide exposure and Parkinson's disease: epidemiological evidence of association. Neurotoxicology. 2012;33(5):947-71. | spa |
| dcterms.references | A Velarde-Avalos AA, FC Arrezola-Tejeda, Castañedad-Achutigui F. Modelos clásicos de inducción de parkinsonismo y su comparación con la fisiopatología de la enfermedad de Parkinson. Revista Mexicana de Neurociencia. 2016;17(3):90-9. | spa |
| dcterms.references | Noyce AJ, Bestwick JP, Silveira‐Moriyama L, Hawkes CH, Giovannoni G, Lees AJ, et al. Meta‐analysis of early nonmotor features and risk factors for Parkinson disease. Annals of neurology. 2012;72(6):893-901. | spa |
| dcterms.references | Jaramillo-Colorado BE, Palacio-Herrera F, Pérez-Sierra I. Residuos de pesticidas organofosforados en frutas obtenidas de plazas de mercado y supermercados en Cartagena, Colombia. Revista Ciencias Técnicas Agropecuarias. 2016;25(4):39-46. | |
| dcterms.references | Yanggen D, Crissman CC, Espinosa P. Los plaguicidas: impactos en producción, salud y medio ambiente en Carchi, Ecuador: Editorial Abya Yala; 2003. | |
| dcterms.references | Wang A, Costello S, Cockburn M, Zhang X, Bronstein J, Ritz B. Parkinson’s disease risk from ambient exposure to pesticides. European journal of epidemiology. 2011;26(7):547-55. | |
| dcterms.references | Aguilera M. Montes de María: una subregión de economía campesina y empresarial. BANCO DE LA REPÚBLICA-ECONOMÍA REGIONAL, 2013. | |
| dcterms.references | Mostafalou S, Abdollahi M. Pesticides: an update of human exposure and toxicity. Archives of toxicology. 2017;91(2):549-99. | |
| dcterms.references | Dick FD. Parkinson's disease and pesticide exposures. British medical bulletin. 2006;79(1):219-31. | |
| dcterms.references | Kim K-H, Kabir E, Jahan SA. Exposure to pesticides and the associated human health effects. Science of The Total Environment. 2017;575:525-35. | |
| dcterms.references | Gilden RC, Huffling K, Sattler B. Pesticides and health risks. Journal of Obstetric, Gynecologic, & Neonatal Nursing. 2010;39(1):103-10. | |
| dcterms.references | del Puerto Rodríguez AM, Suárez Tamayo S, Palacio Estrada DE. Efectos de los plaguicidas sobre el ambiente y la salud. Revista Cubana de Higiene y Epidemiología. 2014;52(3):372-87. | |
| dcterms.references | Ortíz I, Avila-Chávez MA, Torres LG. Plaguicidas en México: usos, riesgos y marco regulatorio. Revista Latinoamericana de Biotecnología Ambiental y Algal. 2013;4(1):1-21. | |
| dcterms.references | LA ALIMENTACIÓN Y. Código Internacional de Conducta para la Distribución y Utilización de Plaguicidas. | |
| dcterms.references | León-Verastegui ÁG. Enfermedad de Parkinson por exposición ocupacional a paraquat. Revista Médica del Instituto Mexicano del Seguro Social. 2012;50(6). | |
| dcterms.references | Tanner CM, Goldman SM, Ross GW, Grate SJ. The disease intersection of susceptibility and exposure: chemical exposures and neurodegenerative disease risk. Alzheimer's & dementia. 2014;10(3):S213-S25. | |
| dcterms.references | Garcia FP, Ascencio SYC, Oyarzun JCG, Hernandez AC, Alavarado PV. Pesticides: classification, uses and toxicity. Measures of exposure and genotoxic risks. Int J Environ Sci Toxic Res. 2012;1:279-93. | |
| dcterms.references | Henao S, Finkelman J, Koning HWd. Plaguicidas y salud en las Américas. OPS serie ambiental: OPS; 1993. | |
| dcterms.references | López Carrillo L. Exposición a plaguicidas organofosforados: Instituto Nacional de Salud Pública; 1993. | |
| dcterms.references | Ramírez J, Lacasaña M. Plaguicidas: clasificación, uso, toxicología y medición de la exposición. Arch Prev Riesgos Labor. 2001;4(2):67-75 | |
| dcterms.references | Serrano Mena LV, Gómez C, Vicente J. Proyecto investigación 2009-descripción y manejo de productos contaminantes, peligrosos o tóxicos utilizados en el hogar. recomendaciones prácticas. 2009 | |
| dcterms.references | Mayeux R. Epidemiology of neurodegeneration. Annual review of neuroscience. 2003;26(1):81-104. | |
| dcterms.references | Willis A. Parkinson disease in the elderly adult. Missouri medicine. 2013;110(5):406-10. | |
| dcterms.references | Hurtado F, Cardenas N, Andrea M, Cárdenas F, León LA. La enfermedad de Parkinson: etiologia, tratamientos y factores preventivos. Universitas Psychologica. 2016;15(spe5):1-26. | |
| dcterms.references | Arriaga AC, Violante MR, Ordóñez AC, Latapi PG, Ruiz ML, Bellmann IE, et al. Tiempo desde el inicio de los síntomas motores hasta el diagnóstico de enfermedad de Parkinson (EP) en México. Gaceta Médica de México. 2014;150(S2):242-7. | |
| dcterms.references | Singh M, Khan AJ, Shah PP, Shukla R, Khanna V, Parmar D. Polymorphism in environment responsive genes and association with Parkinson disease. Molecular and cellular biochemistry. 2008;312(1-2):131-8. | |
| dcterms.references | Dickson DW, Braak H, Duda JE, Duyckaerts C, Gasser T, Halliday GM, et al. Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria. The Lancet Neurology. 2009;8(12):1150-7. | |
| dcterms.references | Poewe W, Seppi K, Tanner CM, Halliday GM, Brundin P, Volkmann J, et al. Parkinson disease. Nature Reviews Disease Primers. 2017;3:17013. | |
| dcterms.references | Uversky VN, Li J, Fink AL. Pesticides directly accelerate the rate of α‐synuclein fibril formation: a possible factor in Parkinson's disease. FEBS letters. 2001;500(3):105-8. | |
| dcterms.references | Braak H, Del Tredici K, Rüb U, De Vos RA, Steur ENJ, Braak E. Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiology of aging. 2003;24(2):197-211. | |
| dcterms.references | Nalls MA, Pankratz N, Lill CM, Do CB, Hernandez DG, Saad M, et al. Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease. Nature genetics. 2014;46(9):989-93. | |
| dcterms.references | Berstad K, Berstad JE. Parkinson's disease; the hibernating spore hypothesis. Medical Hypotheses. 2017 | |
| dcterms.references | Vekrellis K, Xilouri M, Emmanouilidou E, Rideout HJ, Stefanis L. Pathological roles of α-synuclein in neurological disorders. The Lancet Neurology. 2011;10(11):1015-25. | |
| dcterms.references | Wales P, Pinho R, Lázaro DF, Outeiro TF. Limelight on alpha-synuclein: pathological and mechanistic implications in neurodegeneration. Journal of Parkinson's disease. 2013;3(4):415-59. | |
| dcterms.references | Burré J. The synaptic function of α-synuclein. Journal of Parkinson's disease. 2015;5(4):699-713. | |
| dcterms.references | Soldner F, Stelzer Y, Shivalila CS, Abraham BJ, Latourelle JC, Barrasa MI, et al. Parkinson-associated risk variant in distal enhancer of α-synuclein modulates target gene expression. Nature. 2016;533(7601):95-9. | |
| dcterms.references | Melki R. Role of different alpha-synuclein strains in synucleinopathies, similarities with other neurodegenerative diseases. Journal of Parkinson's disease. 2015;5(2):217-27. | |
| dcterms.references | Kim C, Lee SJ. Controlling the mass action of α‐synuclein in Parkinson’s disease. Journal of neurochemistry. 2008;107(2):303-16. | |
| dcterms.references | Dauer W, Przedborski S. Parkinson's disease: mechanisms and models. Neuron. 2003;39(6):889-909. | |
| dcterms.references | Schapira A. Mitochondrial dysfunction in Parkinson's disease. Nature Publishing Group; 2007. | |
| dcterms.references | Bose A, Beal MF. Mitochondrial dysfunction in Parkinson's disease. Journal of neurochemistry. 2016. | |
| dcterms.references | Devi L, Raghavendran V, Prabhu BM, Avadhani NG, Anandatheerthavarada HK. Mitochondrial import and accumulation of α-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain. Journal of Biological Chemistry. 2008;283(14):9089-100. | |
| dcterms.references | Ekstrand MI, Terzioglu M, Galter D, Zhu S, Hofstetter C, Lindqvist E, et al. Progressive parkinsonism in mice with respiratory-chain-deficient dopamine neurons. Proceedings of the National Academy of Sciences. 2007;104(4):1325-30. | |
| dcterms.references | Sossi V, de la Fuente-Fernández R, Holden JE, Schulzer M, Ruth TJ, Stoessl J. Changes of dopamine turnover in the progression of Parkinson's disease as measured by positron emission tomography: their relation to disease-compensatory mechanisms. Journal of Cerebral Blood Flow & Metabolism. 2004;24(8):869-76. | |
| dcterms.references | Kordower JH, Olanow CW, Dodiya HB, Chu Y, Beach TG, Adler CH, et al. Disease duration and the integrity of the nigrostriatal system in Parkinson’s disease. Brain. 2013;136(8):2419-31. | |
| dcterms.references | Lamberts JT, Hildebrandt EN, Brundin P. Spreading of α-synuclein in the face of axonal transport deficits in Parkinson's disease: a speculative synthesis. Neurobiology of disease. 2015;77:276-83. | |
| dcterms.references | Dias V, Junn E, Mouradian MM. The role of oxidative stress in Parkinson's disease. Journal of Parkinson's disease. 2013;3(4):461-91. | |
| dcterms.references | Di Nottia M, Masciullo M, Verrigni D, Petrillo S, Modoni A, Rizzo V, et al. DJ‐1 modulates mitochondrial response to oxidative stress: clues from a novel diagnosis of PARK7. Clinical genetics. 2017;92(1):18-25 | |
| dcterms.references | Guzman JN, Sanchez-Padilla J, Wokosin D, Kondapalli J, Ilijic E, Schumacker PT, et al. Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1. Nature. 2010;468(7324):696-700. | |
| dcterms.references | Bolam JP, Pissadaki EK. Living on the edge with too many mouths to feed: why dopamine neurons die. Movement Disorders. 2012;27(12):1478-83. | |
| dcterms.references | Pissadaki EK, Bolam JP. The energy cost of action potential propagation in dopamine neurons: clues to susceptibility in Parkinson's disease. Frontiers in computational neuroscience. 2013;7. | |
| dcterms.references | Surmeier DJ, Guzman JN, Sanchez-Padilla J, Schumacker PT. The role of calcium and mitochondrial oxidant stress in the loss of substantia nigra pars compacta dopaminergic neurons in Parkinson's disease. Neuroscience. 2011;198:221-31. | |
| dcterms.references | Surmeier DJ, Schumacker PT, Guzman JD, Ilijic E, Yang B, Zampese E. Calcium and Parkinson's disease. Biochemical and biophysical research communications. 2017;483(4):1013-9. | |
| dcterms.references | Mosharov EV, Larsen KE, Kanter E, Phillips KA, Wilson K, Schmitz Y, et al. Interplay between cytosolic dopamine, calcium, and α-synuclein causes selective death of substantia nigra neurons. Neuron. 2009;62(2):218-29. | |
| dcterms.references | Lotharius J, Brundin P. Pathogenesis of Parkinson's disease: dopamine, vesicles and α-synuclein. Nature Reviews Neuroscience. 2002;3(12):932-42. | |
| dcterms.references | Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, et al. MDS clinical diagnostic criteria for Parkinson's disease. Movement Disorders. 2015;30(12):1591-601. | |
| dcterms.references | Rodriguez-Oroz MC, Jahanshahi M, Krack P, Litvan I, Macias R, Bezard E, et al. Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms. The Lancet Neurology. 2009;8(12):1128-39. | |
| dcterms.references | Alcalay RN, Caccappolo E, Mejia-Santana H, Tang MX, Rosado L, Ross BM, et al. Frequency of known mutations in early-onset Parkinson disease: implication for genetic counseling: the consortium on risk for early onset Parkinson disease study. Archives of neurology. 2010;67(9):1116-22. | |
| dcterms.references | Marder KS, Tang MX, Mejia-Santana H, Rosado L, Louis ED, Comella CL, et al. Predictors of parkin mutations in early-onset Parkinson disease: the consortium on risk for early-onset Parkinson disease study. Archives of neurology. 2010;67(6):731-8. | |
| dcterms.references | Chaudhuri KR, Schapira AH. Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment. The Lancet Neurology. 2009;8(5):464-74. | |
| dcterms.references | Scollo SD, Emanuel F, Crimi D, Rodríguez-Quiroga SA, Christie C, Díaz-Arangunde V, et al. Progresión clínica de la enfermedad de Parkinson: análisis retrospectivo en un consultorio especializado en trastornos del movimiento. Neurología Argentina. 2016;8(4):258-62. | |
| dcterms.references | Lorberboym M, Treves TA, Melamed E, Lampl Y, Hellmann M, Djaldetti R. [123I]‐FP/CIT SPECT imaging for distinguishing drug‐induced parkinsonism from Parkinson's disease. Movement disorders. 2006;21(4):510-4 | |
| dcterms.references | Plotkin M, Amthauer H, Klaffke S, Kühn A, Lüdemann L, Arnold G, et al. Combined 123 I-FP-CIT and 123 I-IBZM SPECT for the diagnosis of parkinsonian syndromes: study on 72 patients. Journal of neural transmission. 2005;112(5):677-92. | |
| dcterms.references | Mahlknecht P, Krismer F, Poewe W, Seppi K. Meta‐analysis of dorsolateral nigral hyperintensity on magnetic resonance imaging as a marker for Parkinson's disease. Movement Disorders. 2017;32(4):619-23. | |
| dcterms.references | Tuite P. Magnetic resonance imaging as a potential biomarker for Parkinson's disease. Translational Research. 2016;175:4-16. | |
| dcterms.references | Marras C, Lang A, van de Warrenburg BP, Sue CM, Tabrizi SJ, Bertram L, et al. Nomenclature of genetic movement disorders: Recommendations of the international Parkinson and movement disorder society task force. Movement Disorders. 2016;31(4):436-57. | |
| dcterms.references | Lill CM. Genetics of Parkinson's disease. Molecular and cellular probes. 2016;30(6):386-96. | |
| dcterms.references | Brundin P, Atkin G, Lamberts JT. Basic science breaks through: new therapeutic advances in Parkinson's disease. Movement Disorders. 2015;30(11):1521-7. | |
| dcterms.references | Hatcher JM, Pennell KD, Miller GW. Parkinson's disease and pesticides: a toxicological perspective. Trends in pharmacological sciences. 2008;29(6):322-9. | |
| dcterms.references | Banerjee R, Starkov AA, Beal MF, Thomas B. Mitochondrial dysfunction in the limelight of Parkinson's disease pathogenesis. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease. 2009;1792(7):651-63. | |
| dcterms.references | Campdelacreu J. Parkinson's disease and Alzheimer disease: environmental risk factors. Neurología (English Edition). 2014;29(9):541-9. | |
| dcterms.references | Navarro-Meza M, Morales-Sánchez EW, Pacheco-Moisés F, Ortiz GG. Hábitos alimentarios y factores sociodemográficos de pacientes con enfermedad de Parkinson en zonas rurales. Nutrición Hospitalaria. 2015;32(6):2783-91. | |
| dcterms.references | Cuevas-Esteban J, Campayo A, Haro JM, Guerrero-Morcillo A, Lobo A. Parkinsonismo, depresión y demencia: una tríada asoladora que debe investigarse. 2016. | |
| dcterms.references | Liou H, Tsai M, Chen C, Jeng J, Chang Y, Chen S, et al. Environmental risk factors and Parkinson's disease A case‐control study in Taiwan. Neurology. 1997;48(6):1583-8. | |
| dcterms.references | Breckenridge CB, Berry C, Chang ET, Sielken Jr RL, Mandel JS. Association between Parkinson’s disease and cigarette smoking, rural living, well-water consumption, farming and pesticide use: systematic review and meta-analysis. PloS one. 2016;11(4):e0151841. | |
| dcterms.references | Toledo P, Bustamante G, Cartier L. Espontánea reversibilidad de un síndrome de Parkinson tardío y de alteraciones cognitivas frontales, después de una intoxicación aguda con órganofosforados. Revista chilena de neuro-psiquiatría. 2010;48(3):207-12. | |
| dcterms.references | Badii MH, Varela S. Insecticidas organofosforados: efectos sobre la salud y el ambiente. CULCyT. 2015(28). | |
| dcterms.references | Shahar E, Bentur Y, Bar-Joseph G, Cahana A, Hershman E. Extrapyramidal parkinsonism complicating acute organophosphate insecticide poisoning. Pediatric neurology. 2005;33(5):378-82. | |
| dcterms.references | Greenlee AR, Burmester JK, Hiner BC. Pesticide exposure, host susceptibility factors and risk of Parkinson's disease: an introduction to a work in progress. WMJ: official publication of the State Medical Society of Wisconsin. 2002;101(5):20. | |
| dcterms.references | Vaccari C, El Dib R, de Camargo JLV. Paraquat and Parkinson’s disease: a systematic review protocol according to the OHAT approach for hazard identification. Systematic reviews. 2017;6(1):98. | |
| dcterms.references | Thiruchelvam M, McCormack A, Richfield EK, Baggs RB, Tank AW, Di Monte DA, et al. Age‐related irreversible progressive nigrostriatal dopaminergic neurotoxicity in the paraquat and maneb model of the Parkinson's disease phenotype. European Journal of Neuroscience. 2003;18(3):589-600. | |
| dcterms.references | Brown TP, Rumsby PC, Capleton AC, Rushton L, Levy LS. Pesticides and Parkinson’s disease—is there a link? Environmental health perspectives. 2006;114(2):156. | |
| dcterms.references | Manning-Bog AB, McCormack AL, Li J, Uversky VN, Fink AL, Di Monte DA. The Herbicide Paraquat Causes Up-regulation and Aggregation of α-Synuclein in Mice PARAQUAT AND α-SYNUCLEIN. Journal of Biological Chemistry. 2002;277(3):1641-4. | |
| dcterms.references | Bonneh-Barkay D, Reaney SH, Langston WJ, Di Monte DA. Redox cycling of the herbicide paraquat in microglial cultures. Molecular brain research. 2005;134(1):52-6. | |
| dcterms.references | Ramachandiran S, Hansen JM, Jones DP, Richardson JR, Miller GW. Divergent mechanisms of paraquat, MPP+, and rotenone toxicity: oxidation of thioredoxin and caspase-3 activation. Toxicological Sciences. 2006;95(1):163-71. | |
| dcterms.references | Castello PR, Drechsel DA, Patel M. Mitochondria are a major source of paraquat-induced reactive oxygen species production in the brain. Journal of biological chemistry. 2007;282(19):14186-93. | |
| dcterms.references | Chang X, Lu W, Dou T, Wang X, Lou D, Sun X, et al. Paraquat inhibits cell viability via enhanced oxidative stress and apoptosis in human neural progenitor cells. Chemico-biological interactions. 2013;206(2):248-55. | |
| dcterms.references | Tanner CM, Kamel F, Ross GW, Hoppin JA, Goldman SM, Korell M, et al. Rotenone, paraquat, and Parkinson’s disease. Environmental health perspectives. 2011;119(6):866. | |
| dcterms.references | Costello S, Cockburn M, Bronstein J, Zhang X, Ritz B. Parkinson's disease and residential exposure to maneb and paraquat from agricultural applications in the central valley of California. American journal of epidemiology. 2009;169(8):919-26. | |
| dcterms.references | Garcia-Garcia A, Zavala-Flores L, Rodriguez-Rocha H, Franco R. Thiol-redox signaling, dopaminergic cell death, and Parkinson's disease. Antioxidants & redox signaling. 2012;17(12):1764-84. | |
| dcterms.references | Mazzetti AP, Fiorile MC, Primavera A, Bello ML. Glutathione transferases and neurodegenerative diseases. Neurochemistry international. 2015;82:10-8. | |
| dcterms.references | Goldman SM, Kamel F, Ross GW, Bhudhikanok GS, Hoppin JA, Korell M, et al. Genetic modification of the association of paraquat and Parkinson's disease. Movement Disorders. 2012;27(13):1652-8. | |
| dcterms.references | Thakolwiboon S, Julayanont P, Ruthirago D. Pesticides and Parkinson’s disease: A potential hazard in agricultural communities. The Southwest Respiratory and Critical Care Chronicles. 2017;5(20):60-7. | |
| dcterms.references | Pezzoli G, Cereda E. Exposure to pesticides or solvents and risk of Parkinson disease. Neurology. 2013;80(22):2035-41. | |
| dcterms.references | Dardiotis E, Xiromerisiou G, Hadjichristodoulou C, Tsatsakis AM, Wilks MF, Hadjigeorgiou GM. The interplay between environmental and genetic factors in Parkinson's disease susceptibility: the evidence for pesticides. Toxicology. 2013;307:17-23. | |
| dcterms.references | Kamel F. Paths from Pesticides to Parkinson's. Science. 2013;341(6147):722-3. | |
| dcterms.references | Stykel MG, Humphries K, Kirby MP, Czaniecki C, Wang T, Ryan T, et al. Nitration of microtubules blocks axonal mitochondrial transport in a human pluripotent stem cell model of Parkinson’s disease. The FASEB Journal. 2018:fj. 201700759RR. | |
| dcterms.references | Subramaniam SR, Chesselet M-F. Mitochondrial dysfunction and oxidative stress in Parkinson's disease. Progress in neurobiology. 2013;106:17-32. | |
| dspace.entity.type | Publication | |
| oaire.accessrights | http://purl.org/coar/access_right/c_abf2 | spa |
| oaire.version | http://purl.org/coar/version/c_970fb48d4fbd8a85 | spa |
Sede: Claustro de San Agustín, Centro Histórico, Calle de la Universidad Cra. 6 #36-100
Colombia, Bolívar, Cartagena
Ver más...
